N@N

Ligand to Present at the Citi 2011 Global Healthcare Conference on March 2

_{//health-fitness.news-articles.net/content/2011/ .. 011-global-healthcare-conference-on-march-2.html}
^{Published in Health and Fitness on Wednesday, February 23rd 2011 at 13:55 GMT by Market Wire}  

SAN DIEGO--([ BUSINESS WIRE ])--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that President and Chief Executive Officer John Higgins will present at the Citi 2011Global Healthcare Conference on Wednesday, March 2 at 10:00 a.m. Eastern time (7:00 a.m. Pacific). The conference takes place at the Hilton New York.

A live webcast of the presentation will be available on the Companya�s website [ www.ligand.com ]. A replay of the presentation will be archived on the site for 30 days.

About Ligand Pharmaceuticals

Ligand is a BioPharma company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them to an efficiently lean corporate cost structure. Liganda�s goal is to produce a bottom line that supports a sustainably profitable business. By diversifying the portfolio of assets across numerous technology types, therapeutic areas, drug targets, and industry partners, we offer investors a de-risked opportunity to invest in the increasingly complicated and unpredictable pharmaceutical industry. We believe Ligand has assembled one of the largest and most diversified portfolio of current assets in the industry for a company of its size, currently exceeding 60 programs, with the potential to generate revenue in the future. These therapies address the unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's disease, dyslipidemia, diabetes, anemia, COPD, asthma, rheumatoid arthritis, osteoporosis and cancer. Ligand has established multiple alliances with the world's leading pharmaceutical companies including GlaxoSmithKline, Merck, Pfizer, Bristol-Myers Squibb and AstraZeneca. For more information, please visit [ www.ligand.com ].